Connecticut § 32-41nn Bond authorization for Regenerative Medicine Research Fund.

Connecticut Statutes

§ 32-41nn — Bond authorization for Regenerative Medicine Research Fund.

Connecticut·Title 32 Commerce and Economic and Community Development·Ch. 581 Innovation Capital Act of 1989. Connecticut Innovations, Incorporated

(a)For the purposes described in subsection (b) of this section, the State Bond Commission shall have the power from time to time to authorize the issuance of bonds of the state in one or more series and in principal amounts not exceeding in the aggregate ten million dollars.

(b)The proceeds of the sale of said bonds, to the extent of the amount stated in subsection (a) of this section, shall be used by Connecticut Innovations, Incorporated, for the purposes of the Regenerative Medicine Research Fund established by section 32-41kk .

(c)All provisions of section 3-20 , or the exercise of any right or power granted thereby, which are not inconsistent with the provisions of this section are hereby adopted and shall apply to all bonds authorized by the State Bond Commission pursuant to this

Free access — add to your briefcase to read the full text and ask questions with AI

(a) For the purposes described in subsection (b) of this section, the State Bond Commission shall have the power from time to time to authorize the issuance of bonds of the state in one or more series and in principal amounts not exceeding in the aggregate ten million dollars. (b) The proceeds of the sale of said bonds, to the extent of the amount stated in subsection (a) of this section, shall be used by Connecticut Innovations, Incorporated, for the purposes of the Regenerative Medicine Research Fund established by section 32-41kk . (c) All provisions of section 3-20 , or the exercise of any right or power granted thereby, which are not inconsistent with the provisions of this section are hereby adopted and shall apply to all bonds authorized by the State Bond Commission pursuant to this section, and temporary notes in anticipation of the money to be derived from the sale of any such bonds so authorized may be issued in accordance with said section 3-20 and from time to time renewed. Such bonds shall mature at such time or times not exceeding twenty years from their respective dates as may be provided in or pursuant to the resolution or resolutions of the State Bond Commission authorizing such bonds. None of said bonds shall be authorized except upon a finding by the State Bond Commission that there has been filed with it a request for such authorization which is signed by or on behalf of the Secretary of the Office of Policy and Management and states such terms and conditions as said commission, in its discretion, may require. Said bonds issued pursuant to this section shall be general obligations of the state and the full faith and credit of the state of Connecticut are pledged for the payment of the principal of and interest on said bonds as the same become due, and accordingly and as part of the contract of the state with the holders of said bonds, appropriation of all amounts necessary for punctual payment of such principal and interest is hereby made, and the State Treasurer shall pay such principal and interest as the same become due.

Connecticut § 32-41nn (Bond authorization for Regenerative Medicine Research Fund.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

(P.A. 14-98, S. 22; June Sp. Sess. P.A. 17-2, S. 453.) History: P.A. 14-98 effective July 1, 2015; June Sp. Sess. P.A. 17-2 amended Subsec. (a) by reducing the authorization from $40,000,000 to $10,000,000 and deleting Subdivs. (1), (2), and (3) re effective dates of authorization, effective October 31, 2017.